This work expands the knowledge on phospholipid metabolism in the kinetoplastid parasites: T. brucei, T. cruzi, Leishmania spp. that cause neglected tropical diseases and the related non-human pathogenic Crithidia fasiculata. As a close relative of parasitic kinetoplasts, specifically Leishmania, it is hypothesised that Crithidia fasiculata possesses a similar lipid biosynthetic capability and therefore represent an attractive model organism. Database mining the Crithidia genome revealed the ability to biosynthesise all of the main phospholipid species. Utilising various lipidomic techniques, a high level of an ω-6 18:3 fatty acid was observed, alongside an uncommon Δ19:0 fatty acid that was later identified to be exclusive attributed to PE species. Sphingolipid metabolism was shown to resemble that of Leishmania and T. cruzi, given the exclusive production of inositol-phosphoceramide species and no sphingomyelin species being observed. Using labelled precursors, Crithidia were seen to uptake and incorporate extracellular inositol into both phosphatidylinositol and inositol-phosphoceramide species. Crithidia were also shown to utilise both the Kennedy pathway and methylation of phosphatidylethanolamine to form phosphatidylcholine. The phospholipidome of T. cruzi revealed several phosphatidylserine species for the first time, suggesting a functional phosphatidylserine synthase. Current knowledge of T.cruzi sphingolipid biosynthesis was also confirmed as only inositol xxxi phosphoceramide species were observed. The identification and subsequent characterisation of novel phosphonolipid species are reported for the first time. Utilising lipidomic methodologies and labelled precursors, the relative contribution of the intracellular inositol pools within bloodstream and procyclic T. brucei towards PI biosynthesis was examined. This highlighted that the synthesis/turnover rates for specific phosphatidylinositol and inositol-phosphoceramide species are unequal. Efforts to optimise media conditions highlighted that under reduced levels of serum/glucose/inositol, bloodstream T. brucei unexpectedly adjusts its inositol metabolism. The procyclic parasite exemplifies this fact, as under inositol/glucose deficient media conditions they appear to have adapted to utilising glucogenesis and inositol de-novo synthesis. This work highlights that these parasites are rapidly dividing, their unique features of lipid metabolism may be exploitable for drug discovery purposes.

Les aliments riches en acides gras polyinsaturés (AGPI) à longue chaîne (LC) de la série n-3 sont recommandés pour leurs effets bénéfiques sur la santé humaine et en particulier dans la prevention du développement des maladies métaboliques. Or, la biodisponibilité de ces AGPI et leur impact métabolique pourraient être modulés par la nature chimique des molécules qui les véhiculent dans les aliments (triacylglycérols, TG ou phospholipides, PL). De plus, ces AGPI sont sensibles à la peroxydation lipidique. S’ils ne sont pas protégés de l’oxydation, ils peuvent former des espèces réactives toxiques comme le 4-hydroxy-hexénal (4-HHE). Dans ce contexte, le but de notre étude a été d’évaluer l’impact de l’enrichissement de régimes hyperlipidiques en AGPI n-3 (i) portés par des TG ou des PL et (ii) sous forme non-oxydée ou oxydée, sur l’inflammation et le stress oxydant métaboliques et d’en comprendre certains mécanismes liés à l’absorption intestinale et la réactivité du 4-HHE. D’une part, notre étude a confirmé que la consommation d’AGPI-LC n-3 empêche l’induction du stress oxydant et de l’inflammation lors d’un régime hyperlipidique chez la souris. Cependant, par rapport aux TG, les PL vecteurs d’AGPI n-3 permettent de réduire la taille des adipocytes et de stimuler le système antioxydant. D’autre part, notre étude a montré que la consommation d’AGPI n-3 oxydés de manière modérée aboutit à une élévation des concentrations plasmatiques de 4-HHE et des marqueurs inflammatoires. De plus, une activation des voies inflammatoires ainsi que du stress du réticulum endoplasmique ont été détectées au niveau de l’intestin grêle. Nos résultats in vivo et in vitro sur cellules intestinales Caco-2/TC7 indiquent que cela peut être dû en partie à une absorption au niveau intestinal du 4-HHE, produit d’oxydations des AGPI n-3. Dans le contexte du développement des aliments contenant des AGPI-LC n-3, nos résultats contribuent à identifier les structures vectrices de ces acides gras les plus efficaces du point de vue métabolique. En santé publique et en pratique clinique, nos résultats constituent une nouvelle base de réflexion pour la mise en place de bonnes pratiques de production et de conservation des aliments et des compléments nutritionnels enrichis en AGPI-LC n-3 pour éviter leur oxydation et ses possibles effets délétères. / Dietary intake of n-3 long chain (LC) polyunsaturated fatty acids (PUFA) are recommended for their beneficial effects on human health, especially to prevent the development of metabolic diseases. However, the bioavailability of these PUFAs and their metabolic impact could be modulated by their chemical carriers (triacylglycerols, TG or phospholipids, PL). In addition, these PUFA are susceptible to lipid peroxidation. If they are not protected from oxidation, they can form toxic reactive species such as 4-hydroxy-hexenal (4-HHE). In this context, the aim of our study was to evaluate the impact of enriching high-fat diets with n-3 PUFA (i) bound to TG or PL and (ii) in unoxidized or oxidized form on the generation of inflammation and oxidative stress, and to understand some underlying mechanisms associated with intestinal absorption and reactivity of 4-HHE. On the one hand, our study confirmed in mice that the consumption of n-3 PUFA protects against oxidative stress and inflammation induced by high-fat diets. However, compared to TG, n-3 PUFA in the form of PL reduce the size of adipocytes and stimulate the antioxidant system. On the other hand, our study showed that the consumption of moderately oxidized n-3 PUFA results in increased plasma concentrations of 4-HHE and of inflammatory markers. In addition, activation of inflammatory pathways as well as endoplasmic reticulum stress were detected in the small intestine. Our results in vivo and in vitro, using intestinal Caco-2/TC7 cells, indicate that this can be partly due to the intestinal absorption of the end-product of n-3 PUFA oxidation, 4-HHE. In the context of the development of foods containing LC n-3 PUFA, our results contribute to identify the most effective PUFA carriers on a metabolic standpoint. Regarding public health and clinical practice, our results provide new basis for the set up of best practices regarding production and storage of food and supplements enriched with LC n-3 PUFA to avoid their lipid oxidation and its possible deleterious effects.

Le diabète de type 2 (DT2) est associé à un risque athéro-thrombotique élevé, en partie dû à l'hyperactivation plaquettaire et aux dyslipoprotéinémies. Les lipoprotéines de haute densité (HDL) possèdent des propriétés anti-athérogènes et subissent des modifications glycoxydatives lors du DT2. Notre objectif a été de déterminer les effets d'HDL glycoxydées in vitro ou de DT2 sur les plaquettes sanguines humaines et de déterminer leur contenu en lipides oxydés. Les HDL glycoxydées possèdent des proportions moindres d'acides linoléique et arachidonique dans les phospholipides (PL) et esters de cholestérol, des concentrations plus élevées de dialdéhyde malonique et des principaux acides gras hydroxylés (AGOH) dont les 9-HODE, 13- HODE et 15-HETE dans toutes les classes lipidiques, en particulier dans les PL ainsi que des concentrations très faibles de vitamine E comparativement aux HDL contrôles. Les HDL glycoxydées in vitro et de patients DT2 inhibent de façon dose-dépendante l'agrégation plaquettaire induite par le collagène via le récepteur SR-BI. Ces HDL glycoxydées diminuent la phosphorylation des p38 MAPK et cPLA2 plaquettaires. D'autre part, des HDL contrôles enrichies avec le PC(16:0/13-HODE) inhibent fortement l'agrégation comparativement aux HDL contrôles. De plus, les effets des sous-classes d'HDL, HDL 2 & 3, de DT2 et de témoins ont été testés sur l'agrégation plaquettaire. Les HDL2 de DT2 possèdent des concentrations d'AGOH plus élevées que les HDL3 de DT2 et tendent à inhiber plus l'agrégation plaquettaire. En conclusion, nos résultats montrent que les HDL glycoxydées de patients diabétiques ne perdent pas leurs propriétés anti-agrégantes, qui pourraient être médiées par certaines PL oxydés / Type 2 diabetes (T2D) is associated with a high athero-thrombotic risk, partly due to platelet hyperactivation and dyslipoproteinemia. High-density lipoproteins (HDL) possess antiatherogenic properties and undergo glycoxidation changes in T2D. Our objective was to determine the effects of glycoxidized HDL in vitro or from T2D patients on human blood platelets and to identify their oxidized lipid species. Compared to control HDL, glycoxidized HDL have lower proportions of linoleic and arachidonic acids in phospholipids (PL) and cholesteryl esters, higher concentrations of malondialdehyde and main hydroxylated fatty acid (HOFA) including 9-HODE, 13-HODE and 15-HETE in all lipid classes, especially in PL, and very low concentrations of vitamin E. In vitro glycoxidized and T2D HDL dose-dependently inhibit platelet aggregation induced by collagen via the SR-BI receptor. Glycoxidized HDL decrease the phosphorylation of platelet p38 MAPK and cPLA2. On the other hand, control HDL enriched with oxidized phospholipids i.e. PC(16:0/13-HODE) strongly inhibit platelet aggregation compared to controls. Moreover, the effects of HDL subclasses, HDL 2 & 3, from T2D patients and healthy controls were tested on platelet aggregation. T2D HDL2 have higher concentrations of HOFA than T2D HDL3 and tend to inhibit platelet aggregation to a greater extent. In conclusion, our results show that T2D glycoxidized HDL do not lose their anti-aggregatingproperties and are even more effective than control HDL. These anti-aggregatory effects could be partly due to some oxidized PL species

Le métabolisme des lipides joue un rôle prépondérant dans le cancer. Ce métabolisme a pour effet, particulièrement grâce à la production de phospholipides (PLs), de supporter le niveau accru de prolifération mais aussi de réguler finement des mécanismes intra-cellulaires et extra-cellulaires qui promeuvent le maintien et la progression des cellules cancéreuses. Parmi tous ces acteurs, les gouttelettes lipidiques (GLs), connues pour leur fonction de réservoir, commencent à dévoiler leurs côtés sombres. Notre premier projet nous a permis de mettre en avant l’accumulation de GLs par des cellules de cancer colorectal (CCR) chimiorésistantes. La formation de GLs est régie par l’expression de l’enzyme lysophosphatidylcholine acyltransférase 2 (LPCAT2), permettant la production de phosphatidylcholine. Elle a pour effet de protéger le réticulum endoplasmique (RE) de l’induction d’un stress prévenant l’activation d’une mort cellulaire immunogène. Ces modulations lipidiques peuvent également se retrouver dans le plasma, où elles font l’objet de l’identification de biomarqueurs. Dans ce contexte, nous avons montré dans un second projet, que certains PLs pouvaient diagnostiquer la présence d’un carcinome hépatocellulaire (CHC) sur un foie cirrhotique. Ces deux aspects soulignent l’importance du métabolisme des PLs dans les cancers digestifs. / Among all altered cancer metabolic pathways, lipid metabolism has a preponderant role in cancer development. This metabolism, especially through the production of phospholipids, supports high level of proliferation and carefully regulates intra-cellular and extra-cellular mechanisms promoting maintenance and progression of cancer cells. Among all metabolic players, lipid droplets (LD), known for their storage function, begin to reveal dark sides. Our first project led us to highlight LD involvement in the chemoresistance of colorectal cancer (CRC) cells. This resistance carries out thanks to LD accumulation during chemotherapy treatment. Their accumulation is regulated by the expression of lysophosphatidylcholine acyltransferase 2 (LPCAT2), leading to the production of phosphatidylcholine. It causes the protection of the endoplasmic reticulum (ER) stress induction preventing the activation of immunogenic cell death. These lipid modulations can also be found in plasma where they can be identified as biomarkers. In this context, we have shown that some phospholipids could prognosticate hepatocellular carcinoma (HCC) upon cirrhotic liver. These two aspects highlight the significance of phospholipid metabolism in digestive cancers.

CoordenaÃÃo de AperfeiÃoamento de NÃvel Superior / O presente trabalho teve por objetivo estudar as respostas fisiolÃgicas e bioquÃmicas de clones de cajueiro anÃo-precoce (Anacardium occidentale L.) ao estresse salino. Os experimentos foram conduzidos em casa de vegetaÃÃo, sendo as plÃntulas cultivadas em vasos plÃsticos contendo vermiculita. No primeiro experimento, cinco clones de cajueiro anÃo-precoce foram submetidos aos tratamentos com NaCl a 0 (controle), 8 e 16 dS.m-1 de condutividade elÃtrica e objetivou selecionar clones com tolerÃncias diferenciadas ao estresse salino. Para isso, foram estudados os efeitos da salinidade no crescimento, nas trocas gasosas, no teor de Ãgua, na suculÃncia foliar, no potencial osmÃtico, nas concentraÃÃes de prolina, N-aminossolÃveis e carboidratos solÃveis e nos teores dos Ãons inorgÃnicos (Na+, Cl- e K+). A salinidade reduziu o crescimento das plÃntulas de todos os clones estudados. Os efeitos inibitÃrios do NaCl foram mais conspÃcuos na parte aÃrea do que nas raÃzes. O clone CCP 06 foi aquele que apresentou maior reduÃÃo no crescimento foliar, enquanto os clones BRS 189 e CCP 09 foram os que apresentaram as menores reduÃÃes. A salinidade inibiu a mobilizaÃÃo das reservas cotiledonÃrias, principalmente, na dose mais elevada de sal. A reduÃÃo no crescimento, pela salinidade, correlacionou-se com a reduÃÃo na taxa de fotossÃntese lÃquida. Os clones CCP 06 e BRS 189 apresentaram, respectivamente, a maior e a menor reduÃÃo na taxa fotossintÃtica a 8 dS.m-1. Embora a salinidade tenha reduzido a condutÃncia estomÃtica dos clones de cajueiro anÃo-precoce, essa reduÃÃo nÃo foi acompanhada por mudanÃas nas concentraÃÃes internas de CO2. Os clones estudados nÃo apresentaram alteraÃÃes, em funÃÃo da salinidade, no estado hÃdrico das folhas e raÃzes, porÃm, apresentaram reduÃÃes no potencial osmÃtico, favorecendo o ajustamento osmÃtico e, consequentemente, a manutenÃÃo da turgescÃncia dos tecidos. Sob condiÃÃes de estresse salino, os clones BRS 189 e CCP 09 foram os mais eficientes na regulaÃÃo do transporte do Ãon Na+ para a parte aÃrea da plÃntula, acumulando-o nas raÃzes. Em relaÃÃo ao Cl-, o clone CCP 09 mostrou-se o mais eficiente no controle do transporte desse Ãon. PorÃm, CCP 06 foi o clone que mais acumulou ambos os Ãons tÃxicos na parte aÃrea da planta. Com o aumento da salinidade, os teores de potÃssio dos clones estudados tiveram seus valores reduzidos apenas nas raÃzes. Na dose de 8 dS.m-1, o BRS 189 foi o clone que mais aumento suas concentraÃÃes de N-aminosolÃveis e prolina no suco radicular. Nesse mesmo nÃvel de sal, a salinidade aumentou a concentraÃÃo de carboidratos apenas nos clones CCP 06 e BRS 189. De posse destes resultados, o segundo experimento foi realizado com os clones CCP 06 e BRS 189 que foram os que se mostraram, respectivamente, o menos e o mais tolerante à salinidade. Esse experimento teve por objetivo estudar os efeitos da salinidade (NaCl a 8 dS.m-1) na atividade da H+-ATPase e na composiÃÃo e peroxidaÃÃo dos lipÃdios de membrana plasmÃtica isoladas de raÃzes das plÃntulas dos dois clones contrastantes. A salinidade estimulou a atividade da H+-ATPase apenas no clone tolerante, o BRS 189, sendo esse clone o que apresentou maior conteÃdo de esterÃis totais e menor relaÃÃo fosfolipÃdios totais (PLt)/ esterÃis totais (Et), tanto em condiÃÃes controle como de estresse. Esses resultados foram concordantes com o fato de ter sido o BRS 189 o clone que melhor excluiu o Na+ da parte aÃrea. Nesse clone nÃo foram observadas alteraÃÃes nos teores de malondialdeÃdo, diferentemente do que ocorreu com o CCP 06, cujos teores aumentaram com o estresse salino. A maior proteÃÃo da membrana plasmÃtica do clone BRS 189 ao dano oxidativo està de acordo com os maiores acÃmulos de prolina e N-aminossolÃveis observados nesse clone. Os principais fosfolipÃdios da membrana plasmÃtica isolada de raÃzes do clone BRS 189 foram fosfatilglicerol (PG), fosfatidiletalonamina (PE) e fosfatilserina (PS). A salinidade provocou alteraÃÃes nas proporÃÃes relativas dos fosfolipÃdios, sendo PE e fosfatidilinositol (PI) os que apresentaram maiores aumentos em relaÃÃo ao total, enquanto que fosfatidilglicerol (PG) e Ãcido fosfatÃdico (PA) foram os que apresentaram maiores reduÃÃes. A percentagem de PS, em relaÃÃo ao total, nÃo foi afetada pela salinidade. No entanto, a relaÃÃo entre essas mudanÃas na composiÃÃo lipÃdica do BRS 189 pela salinidade e o aumento na atividade da H+-ATPase necessita ser melhor investigada. / Early-dwarf cashew seedlings (Anacardium occidentale L.) were used in order to investigate the physiological and biochemical changes induced by salt stress. The seeds (nuts) were sown in plastics pots containing vermiculite moistened with either distilled water (control treatment) or NaCl solutions at 8 and 16 dS.m-1 of electrical conductivity (saline treatment), and kept in greenhouse throughout the experimental period. Uniform 28-day-old seedlings were used for the analyses. The first experiment aimed to select, among five clones (CCP 06, CCP 09, CCP 76, Embrapa 51 and BRS 189), the ones showing contrasting salt-tolerance. The effect of salinity on the growth, gas exchange, water content, leaf succulence, osmotic potential and inorganic (Na+, Cl-, K+) and organic (proline, soluble carbohydrates, quaternary ammonium compounds) solute concentration for both salt-sensitive and salt-tolerant clones was studied. Salinity inhibited the growth of all clones studied, being the inhibitory effect on shoot growth more conspicuous than in root growth. Clone CCP 06 leaf area was the most inhibited by salt stress, while clones BRS 189 and CCP 09 leaf areas were the least affected by salinity. Salt stress caused a great decrease in the cotyledon reserve mobilization especially at 16 dS.m-1. Growth reduction was correlated to the reduction in net photosynthetic rate. CCP 06 and BRS 189 showed the greatest and the lowest reduction in photosynthetic rate at 8 dS.m-1, respectively. Although, salinity reduced stomatal conductance, this reduction was not followed by changes in CO2 internal concentration. The water status, expressed as water content in relation to dry mass, was not changed by salt-stress. Salinity induced the lowering of osmotic potential both in leaves and roots of all clones studied. This osmotic adjustment might have lead to turgor maintenance of those tissues. The concentrations of Cl- and Na+ increased with increasing salt stress. Clones BRS 189 and CCP 09 accumulated more Na+ in the roots, and this could explain their efficiency in maintaining a lower ion concentration in shoots, i.e. they regulated more efficiently the transport of Na+ from roots to shoots. The regulation of Cl- transport to shoots was more efficient in clone CCP 09 than in the others. Salinity did not induce significant changes in leaves and stems K+ concentration, but it induced a reduction of K+ concentration in roots. Salinity also induced increases of quaternary ammonium compounds and proline concentration in BRS 189 root at 8 dS.m-1. In addition, this level of salinity increased soluble carbohydrates in the root sap especially in clones BRS 189 and CCP 06. During the second experiment, the effect of salt stress (NaCl at 8 dS.m-1) on the activity of H+-ATPase, lipid composition and peroxidation of root plasma membrane of both salt-tolerant (BRS 189) and salt- sensitive (CCP 06) clones were studied. The vanadate-sensitive H+-ATPase activity was studied in plasma membrane-enriched vesicles isolated by discontinuous sucrose gradient centrifugation from roots. ATP hidrolizing activity in this fraction was mostly inhibited by vanadate and scarcely, by azide and molybdate, indicating that it was essentially enriched in plasma membrane vesicles. Salinity induced a 1.3-fold increase in the H+-ATPase specific activity in roots of BRS 189 seedlings. Salinity had no appreciable effect on the hydrolytic activity of this enzyme during the growth of CCP 06 seedlings. Likewise, clone BRS 189 roots plasma membrane showed higher sterol content and lower phospholipids/total sterol ratio than clone CCP 06. Both properties could contribute to the decrease in Na+ influx or increase in Na+ efflux or âexclusionâ from roots. This could result in less Na+ being transported to the shoot, and thus explaining the higher salt-tolerance of clone BRS 189. The higher degree of root plasma membrane lipid peroxidation of clone, and the lower proline and ammonium quaternary compounds contents of CCP 06 when compared to BRS 189 could also explain the differences in salt-tolerance between the two clones. These organic solutes could protect and stabilize plasma membrane against oxidative stress. Phosphatidylglycerol (PG), phosphatidylethanolamine (PE) and phosphatidylserine (PS) were the major phospholipids in the plasma membrane from BRS 189 roots. Salinity induced increases in the relative proportions of PE and phosphatidylinositol (PI), while PG and PA were reduced. No changes were detected in PS in relation to control plant. The importance of lipid composition changes on H+-ATPase activity must be more studied.

<p>The general aim of the present project was to increase the understanding of the in vivo dissolution of poorly soluble drugs and thereby improve possibility to predict in vivo solubility from substance properties. Increased understanding of the in vivo limitations of drug solubility could potentially also generate ideas for improved formulation principles for poorly soluble compounds and more relevant in vitro dissolution test methods used in formulation development.</p><p>The dynamic gastrointestinal secretory and enzymatic responses to a liquid meal were studied in human intestinal fluid (HIF) by in vivo perfusion of a nutritional drink. The main diversity found compared to simulated intestinal fluids was the presence of dietary lipids in fed human intestinal fluid. This difference was showed to be of importance in the solubility of low soluble drugs, since this parameter was underestimated in the simulated fluid. Thus suggesting that simulated intestinal fluids should be prepared with the addition of dietary lipids for better in vitro in vivo predictions. </p><p>Solubility and dissolution determinations in fasted and fed HIF showed that the solubility was higher in fed state fluid, probably owing to the higher concentration of lipids in this media. The higher solubility was correlated to both the lipophilicity and aqueous solubility of the drug. The dissolution rate also increased, but not to the same extent as the solubility. These findings need to be considered in the design of in vitro models and in the prediction of food effects on oral bioavailability of poorly soluble drugs.</p><p>In addition, an in vivo porcine perfusion study was performed to investigate importance of different mechanisms in food-drug interactions. The results showed that solubilisation might be a more important factor than P-gp inhibition for food-related effects on the intestinal absorption kinetics of Class II drugs. </p>

The general aim of the present project was to increase the understanding of the in vivo dissolution of poorly soluble drugs and thereby improve possibility to predict in vivo solubility from substance properties. Increased understanding of the in vivo limitations of drug solubility could potentially also generate ideas for improved formulation principles for poorly soluble compounds and more relevant in vitro dissolution test methods used in formulation development. The dynamic gastrointestinal secretory and enzymatic responses to a liquid meal were studied in human intestinal fluid (HIF) by in vivo perfusion of a nutritional drink. The main diversity found compared to simulated intestinal fluids was the presence of dietary lipids in fed human intestinal fluid. This difference was showed to be of importance in the solubility of low soluble drugs, since this parameter was underestimated in the simulated fluid. Thus suggesting that simulated intestinal fluids should be prepared with the addition of dietary lipids for better in vitro in vivo predictions. Solubility and dissolution determinations in fasted and fed HIF showed that the solubility was higher in fed state fluid, probably owing to the higher concentration of lipids in this media. The higher solubility was correlated to both the lipophilicity and aqueous solubility of the drug. The dissolution rate also increased, but not to the same extent as the solubility. These findings need to be considered in the design of in vitro models and in the prediction of food effects on oral bioavailability of poorly soluble drugs. In addition, an in vivo porcine perfusion study was performed to investigate importance of different mechanisms in food-drug interactions. The results showed that solubilisation might be a more important factor than P-gp inhibition for food-related effects on the intestinal absorption kinetics of Class II drugs.

Cancer is the second leading cause of death in the United States and its onset is highly incident in the lungs, with very low long-term survival rates. Chemotherapy plays a significant role for lung cancer treatment, and pulmonary delivery may be a potential route for anticancer drug delivery to treat lung tumors. Coenzyme Q₁₀ (CoQ₁₀) is a poorly-water soluble compound that is being investigated for the treatment of carcinomas. In this work, we hypothesize that formulations of CoQ10 may be developed for pulmonary delivery with a satisfactory pharmacokinetic profile that will have the potential to improve a pharmacodynamic response when treating lung malignancies. The formulation design was to use a vibrating-mesh nebulizer to aerosolize aqueous dispersions of CoQ₁₀ stabilized by phospholipids physiologically found in the lungs. In the first study, a method was developed to measure the surface tension of liquids, a physicochemical property that has been shown to influence the aerosol output characteristics from vibrating-mesh nebulizers. Subsequently, this method was used, together with analysis of particle size distribution, zeta potential, and rheology, to further evaluate the factors influencing the capability of this nebulizer system to continuously and steadily aerosolize formulations of CoQ₁₀ prepared with high pressure homogenization. The aerosolization profile (nebulization performance and in vitro drug deposition of nebulized droplets) of formulations prepared with soybean lecithin, dimyristoylphosphatidylcholine (DMPC), dipalmitoylphosphatidylcholine (DPPC) and distearoylphosphatidylcholine (DSPC) were evaluated. The rheological behavior of these dispersions was found to be the factor that may be indicative of the aerosolization output profile. Finally, the pulmonary deposition and systemic distribution of CoQ₁₀ prepared as DMPC, DPPC, and DSPC dispersions were investigated in vivo in mice. It was found that high drug amounts were deposited and retained in the mouse lungs for at least 48 hours post nebulization. Systemic distribution was not observed and deposition in the nasal cavity occurred at a lower scale than in the lungs. This body of work provides evidence that CoQ₁₀ may be successfully formulated as dispersions to be aerosolized using vibrating-mesh nebulizers and achieve high drug deposition in the lungs during inhalation. / text

Cancer is the second leading cause of death in the United States and its onset is highly incident in the lungs, with very low long-term survival rates. Chemotherapy plays a significant role for lung cancer treatment, and pulmonary delivery may be a potential route for anticancer drug delivery to treat lung tumors. Coenzyme Q₁₀ (CoQ₁₀) is a poorly-water soluble compound that is being investigated for the treatment of carcinomas. In this work, we hypothesize that formulations of CoQ10 may be developed for pulmonary delivery with a satisfactory pharmacokinetic profile that will have the potential to improve a pharmacodynamic response when treating lung malignancies. The formulation design was to use a vibrating-mesh nebulizer to aerosolize aqueous dispersions of CoQ₁₀ stabilized by phospholipids physiologically found in the lungs. In the first study, a method was developed to measure the surface tension of liquids, a physicochemical property that has been shown to influence the aerosol output characteristics from vibrating-mesh nebulizers. Subsequently, this method was used, together with analysis of particle size distribution, zeta potential, and rheology, to further evaluate the factors influencing the capability of this nebulizer system to continuously and steadily aerosolize formulations of CoQ₁₀ prepared with high pressure homogenization. The aerosolization profile (nebulization performance and in vitro drug deposition of nebulized droplets) of formulations prepared with soybean lecithin, dimyristoylphosphatidylcholine (DMPC), dipalmitoylphosphatidylcholine (DPPC) and distearoylphosphatidylcholine (DSPC) were evaluated. The rheological behavior of these dispersions was found to be the factor that may be indicative of the aerosolization output profile. Finally, the pulmonary deposition and systemic distribution of CoQ₁₀ prepared as DMPC, DPPC, and DSPC dispersions were investigated in vivo in mice. It was found that high drug amounts were deposited and retained in the mouse lungs for at least 48 hours post nebulization. Systemic distribution was not observed and deposition in the nasal cavity occurred at a lower scale than in the lungs. This body of work provides evidence that CoQ₁₀ may be successfully formulated as dispersions to be aerosolized using vibrating-mesh nebulizers and achieve high drug deposition in the lungs during inhalation.

Μελετήθηκε ο μεταβολισμός της γλυκερόλης στη ζύμη Yarrowia lipolytica ACA–DC 50109 με έμφαση στη μετατροπή της σε λιπίδια και κιτρικό οξύ, μεταβολικά προϊόντα που παρουσιάζουν ιδιαίτερο ενδιαφέρον για τη βιοτεχνολογία. Σε καλλιέργειες που πραγματοποιήθηκαν σε βιοαντιδραστήρα διαλείποντος έργου, επί πολλαπλώς περιοριστικού μέσου, διαπιστώθηκε η ύπαρξη τριών διακριτών φάσεων αύξησης που χαρακτηρίζονται από ιδιαίτερα μορφολογικά και βιοχημικά χαρακτηριστικά: η φάση βιοσύνθεσης κυτταρικής μάζας (κατά την οποία συντέθηκαν 4–4,5 g/l βιομάζας), η ελαιογόνος φάση (κατά την οποία πραγματοποιήθηκε συσσώρευση λιπιδίων 20–22% wt/wt επί ξηρής βιομάζας, 90% wt/wt των οποίων ήταν ουδέτερα) και η φάση παραγωγής κιτρικού οξέος (κατά την οποία εκκρίθηκαν στο περιβάλλον της αύξησης 14–30 g/l κιτρικού οξέος). Κατά τη διάρκεια των ανωτέρω φάσεων η ζύμη διήλθε από διάφορα μορφολογικά στάδια: μικρού μήκους αληθή μυκήλια και ψευδομυκήλια που κυριάρχησαν των κυττάρων ζύμης κατά τη φάση βιοσύνθεσης κυτταρικής μάζας, ευμεγέθη κύτταρα κατά τη φάση της ελαιογένεσης και μικρού μεγέθους κύτταρα ζύμης κατά τη φάση παραγωγής κιτρικού οξέος. Η γλυκερόλη διαπερνά την κυτταροπλασματική μεμβράνη με διευκολυνόμενη διάχυση και καταβολίζεται μέσω των αντιδράσεων της κινάσης της γλυκερόλης – GK και της NAD+ εξαρτώμενης αφυδρογονάσης της 3–P–γλυκερόλης. Την υψηλή ενεργότητα της NAD+ εξαρτώμενης ισοκιτρικής αφυδρογονάσης (NAD+–ICDH) κατά τη διάρκεια της φάσης βιοσύνθεσης κυτταρικής μάζας διαδέχθηκε σημαντική πτώση της ενεργότητάς της, επάγοντας τη λιπογένεση. Απρόσμενη αποδόμηση των αποθεματικών (ουδέτερων) λιπιδίων και σημαντική βιοσύνθεση γλυκολιπιδίων, σφιγγολιπιδίων και φωσφολιπιδίων – Ρ παρατηρήθηκε κατά τη διάρκεια της φάσης παραγωγής κιτρικού οξέος, φάση κατά την οποία η ενεργότητα της GK είχε μειωθεί σημαντικά ενώ η ενεργότητα της NAD+–ICDH είχε σχεδόν μηδενιστεί. Το ελαϊκό οξύ ήταν το κυριότερο λιπαρό οξύ ενώ η φωσφατιδυλχολίνη – PC το κύριο Ρ. Σε συνεχές σύστημα καλλιέργειας επί θρεπτικού υλικού περιοριστικού σε άζωτο, βιοσυντέθηκαν περιορισμένες μόνο ποσότητες λιπιδίων (~10% wt/wt, επί της ξηρής βιομάζας), γεγονός που μπορεί αποδοθεί στο ότι δεν υπήρχε μια περιοχή του ειδικού ρυθμού αραίωσης (D, h–1) στην οποία τα ένζυμα – κλειδιά που εμπλέκονται στη λιπογένεση (όπως η ΑΤΡ:κιτρική λυάση – ATP:CL και το μηλικό ένζυμο – ME) να παρουσιάζουν συγχρόνως υψηλές ενεργότητες, ενώ η ενεργότητα της NAD+–ICDH μειώθηκε, όχι όμως σημαντικά, στους χαμηλούς D. Η ενεργότητα της ATP:CL χαρακτηρίστηκε από υψηλές τιμές (60–300 Units/mg DW) σε D 0,033 h–1 ενώ οι μέγιστες τιμές ενεργότητας του ME (650 Units/mg DW) εμφανίστηκαν σε D=0,104 h–1. Τα λιπίδια της ζύμης ήταν περισσότερο ακόρεστα σε ενδιάμεσες τιμές D. Σε όλους τους D η φωσφατιδυλαιθανολαμίνη – PE, η φωσφατιδυλινοσιτόλη – PI και η PC αντιπροσωπεύουν τις κυριότερες κλάσεις των Ρ. Όσον αφορά τη μορφολογία της ζύμης, βρέθηκε ότι σε D<0,055 h–1 επικρατούσαν αληθή μυκήλια και ψευδομυκήλια ενώ σε D 0,055 h–1 παρατηρήθηκαν μόνο κύτταρα ζύμης. Σε πειράματα που πραγματοποιήθηκαν επί θρεπτικού υλικού περιοριστικού σε άζωτο, σε D=0,026 h–1, σε διαφορετικές συγκεντρώσεις διαλυμένου οξυγόνου – DO παρατηρήθηκε αυξημένο ποσοστό του κλάσματος των Ρ επί των ολικών λιπιδίων στις ακραίες σε τιμές DO ( 70% και 7%). Ανεξάρτητα των τιμών DO η PC ήταν η κλάση με το μεγαλύτερο ποσοστό, ακολουθούμενη από την PI και PE. Ειδικότερα το ποσοστό της ΡΕ παρουσιάστηκε ιδιαίτερα αυξημένο σε ενδιάμεσες τιμές DO (20% και 30%). Σε DΟ 50% επικρατούσαν αληθή μυκήλια και ψευδομυκήλια ενώ σε DΟ 50% εμφανίστηκαν στην καλλιέργεια περισσότερα κύτταρα ζύμης. Σε πειράματα που πραγματοποιήθηκαν σε D=0,026 h–1 βρέθηκε ότι ο περιορισμός της αύξησης από ιχνοστοιχεία όπως το μαγνήσιο και το ασβέστιο τα οποία εμπλέκονται σε πολλαπλές κυτταρικές λειτουργίες, είχαν δυσμενή επίδραση στη φυσιολογία της ζύμης, ωστόσο η σύσταση των λιπιδίων σε λιπαρά οξέα δεν επηρεάστηκε από τη φύση του περιοριστικού για την αύξηση παράγοντα. Η παρούσα διδακτορική διατριβή φιλοδοξεί να συμβάλει στη μελέτη της φυσιολογίας των ελαιογόνων μικροοργανισμών και στη χρήση της γλυκερόλης ως υποστρώματος σε μελλοντικές βιοτεχνολογικές εφαρμογές. / In this thesis the metabolism of glycerol in Yarrowia lipolytica ACA–DC 50109, with emphasis on glycerol conversion into value–added biotechnological products, such as single cell oils and citric acid, was studied. The growth of Y. lipolytica was studied in bioreactor batch cultures in multiple limited medium and three distinct phases were identified during growth cycle. In each phase, yeast cells were characterized by specific morphological and biochemical features: biomass formation phase (in which 4–4.5 g/l of biomass were synthesized), lipogenic phase (in which 20–22% lipids wt/wt in dry weight were accumulated in biomass, containing 90% wt/wt neutral lipids) and citric acid production phase (in which 14–30 g/l of citric acid were secreted in the growth environment). Distinct cellular forms of Y. lipolytica were developed during the above phases: in biomass formation phase short true mycelia and pseudo–mycelia were predominant while a few yeast–like cells were observed, in lipogenic phase large obese cells were predominant and in citric acid production phase cells size was diminished. Glycerol passes into the microbial cell by facilitated diffusion. Y. lipolytica successfully converts glycerol via phosphorylation pathway, in which glycerol kinase (GK) and glycerol–3–P–dehydrogenase are implicated. Though high activity of NAD+ dependent isocitric dehydrogenase (NAD+–ICDH) was detected during biomass formation phase, this activity was significantly decreased afterwards inducing lipogenesis. Surprisingly, storage (neutral) lipid turnover and synthesis of glycolipids, sphingolipids and phospholipids – Ρ simultaneously occurred with citric acid production, and happened when GK activity was considerably reduced and NAD+–ICDH activity was minimised. Oleic acid was the major fatty acid in all lipid fractions and phosphatidylcholine – PC was the main Ρ. In continuous culture in nitrogen limited medium Y. lipolytica accumulated low quantities of lipids (~10% w/w, in dry weight), maybe due to the fact that there was not a region of specific dilution rate (D, h–1) in which the key–enzymes that are implicated in lipogenesis (i.e. ΑΤΡ:citrate lyase – ATP:CL and malic enzyme – ME) presented simultaneously high activity while NAD+–ICDH activity was insignificantly decreased in low D. ATP:CL presented high activity (60–300 Units/mg DW) in D 0,033 h–1 while ME presented maximum activity (650 Units/mg DW) in D=0,104 h–1. Lipids were more unsaturated in intermediate D values while phosphatidylethanolamine – PE, phosphatidylinositol – PI and PC are the main Ρ classes. As far as the morphology is concerned, in D<0,055 h–1 short true mycelia and pseudo–mycelia were predominant in culture medium while in D 0,055 h–1 only yeast cells were observed. In experiments performed in nitrogen limited medium in D=0,026 h–1 in different dissolved oxygen – DO concentrations, it was found that in extreme DO values ( 70% and 7%) the percentage of P was increased. Independently the DO concentration PC was the main class followed by PI and PE. The morphology of Y. lipolytica was influenced by the different concentration of DO and it was observed that in DΟ 50% short true mycelia and pseudo–mycelia were predominant in culture medium while in DΟ 50% more yeast cells were appeared. In experiments performed in D=0,026 h–1, it was found that the absence of micronutrients from the growth medium, i.e. magnesium and calcium that are implicated in multiple cellular functions, had severe effects in yeast physiology, while the fatty acid composition of cellular lipids was not affected by the nature of the growth limiting factor. The present thesis aspires to contribute in the study of oleaginous microorganisms’ physiology and in use of glycerol as substrate in future biotechnological applications.